Home ›
Data Desk › Relmada Therapeutics Inc. reports $5.7M of cash, about 1.3 months at its recent burn
MarginsX Data Desk · Quarterly results · Early-stage clinical trials · Oncology · Late-stage clinical trials
Relmada Therapeutics Inc. reports $5.7M of cash, about 1.3 months at its recent burn
Relmada Therapeutics Inc. (RLMD) filed its 10-Q on Nov 12, 2026, covering the quarter ended Sep 30, 2026. (SEC XBRL company facts, 10-Q, Nov 12, 2026)
By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 12, 2026.
Revenue and margins
The net loss was $13.9M. (SEC XBRL company facts, 10-Q, Nov 12, 2026)
Balance sheet
Cash was $5.7M at Sep 30, 2026, against $11.3M at Jun 30, 2026. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)
Shares outstanding were 106.7 million, against 106.7 million at Jun 30, 2026. (SEC XBRL company facts, 10-Q, Nov 12, 2026)
At its recent quarterly burn of $13.0M, that cash lasts about 1.3 months, by our estimate from its XBRL cash flows. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)
The stock
The Nasdaq screener puts its market value at $443.9M. (Nasdaq stock screener, Nov 13, 2026)
Follow it up
The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/RLMD)
The filing on SEC EDGAR. (sec.gov)
The filing in the MarginsX reader. (MarginsX reader)
Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.
Facts behind this article
| Fact | Value | Source | As of |
|---|
| Name | Relmada Therapeutics Inc. | Source | 2026-11-13 |
| Cash | 5,720,325 USD | Source | 2026-09-30 |
| Runway | 1.3 months | Source | 2026-09-30 |
| Who | Relmada Therapeutics Inc. (RLMD) | Source | 2026-11-13 |
| Symbol | RLMD | Source | 2026-11-13 |
| Form | 10-Q | Source | 2026-11-12 |
| Filed | Nov 12, 2026 | Source | 2026-11-12 |
| Period end | Sep 30, 2026 | Source | 2026-11-12 |
| Net loss | 13,862,188 USD | Source | 2026-11-12 |
| Net income | -13,862,188 USD | Source | 2026-11-12 |
| Cash prior | 11,334,370 USD | Source | 2026-11-12 |
| Prior end | Jun 30, 2026 | Source | 2026-11-12 |
| Shares | 106,694,846 shares | Source | 2026-11-12 |
| Shares prior | 106,669,846 shares | Source | 2026-11-12 |
| Burn abs | 12,963,862.25 USD | Source | 2026-09-30 |
| Burn | -12,963,862.25 USD | Source | 2026-09-30 |
| Cap | 443,850,559 USD | Source | 2026-11-13 |
Sources
Automated from SEC filings and market data. No AI. For information only. Not investment advice.
Discuss in MarginsX More from the Data Desk
More on MarginsX
Companies in this article
Topics
Related Data Desk stories
Every Data Desk article: /desk · RSS